Novartis tries texts to track supplies; China says 13% of capsulemakers were cheating;

> China's State Food and Drug Administration (SFDA) reports that 254 drug capsulemakers it inspected, which represent 12.7% of the industry, were manufacturing capsules that didn't meet standards. Story

> Novartis ($NVS) is leading a supply chain program in Tanzania that uses text messages to help manage malaria drug supplies in public health facilities. Item

> The manufacturers of two dozen drugs that failed quality tests by the Karnataka Drug Control Department in India have been ordered to make changes to their manufacturing. Story

> AptarGroup ($ATR) is buying Stelmi Group, which makes elastomer primary packaging components for injectable drug delivery. Release

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.